Cancer overdiagnosis: a biological challenge and clinical dilemma

S Srivastava, EJ Koay, AD Borowsky… - Nature Reviews …, 2019 - nature.com
For cancer screening to be successful, it should primarily detect cancers with lethal potential
or their precursors early, leading to therapy that reduces mortality and morbidity. Screening …

Cost-effectiveness of colorectal cancer screening strategies—a systematic review

T Ran, CY Cheng, B Misselwitz, H Brenner… - Clinical …, 2019 - Elsevier
Background & Aims Widespread screening for colorectal cancer (CRC) has reduced its
incidence and mortality. Previous studies investigated the economic effects of CRC …

Cost-effectiveness and national effects of initiating colorectal cancer screening for average-risk persons at age 45 years instead of 50 years

U Ladabaum, A Mannalithara, RGS Meester, S Gupta… - Gastroenterology, 2019 - Elsevier
Background & Aims The American Cancer Society has recommended initiating colorectal
cancer (CRC) screening at age 45 years instead of 50 years. We estimated the cost …

Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis

HC Jodal, LM Helsingen, JC Anderson, L Lytvyn… - BMJ open, 2019 - bmjopen.bmj.com
Objective Evaluate effectiveness, harms and burdens of faecal blood testing, sigmoidoscopy
and colonoscopy screening for colorectal cancer over 15 years. Design We performed an …

Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial

EA Miller, PF Pinsky, RE Schoen, PC Prorok… - The lancet …, 2019 - thelancet.com
Background Screening flexible sigmoidoscopy reduces incidence and mortality of colorectal
cancer. Previously reported results from the Prostate, Lung, Colorectal, and Ovarian Cancer …

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study

M Buskermolen, DR Cenin, LM Helsingen, G Guyatt… - Bmj, 2019 - bmj.com
Objective To estimate benefits and harms of different colorectal cancer screening strategies,
stratified by (baseline) 15-year colorectal cancer risk. Design Microsimulation modelling …

Modifiable failures in the colorectal cancer screening process and their association with risk of death

CA Doubeni, SA Fedewa, TR Levin, CD Jensen… - Gastroenterology, 2019 - Elsevier
Background & Aims Colorectal cancer (CRC) deaths occur when patients do not receive
screening or have inadequate follow-up of abnormal results or when the screening test fails …

A review on curability of cancers: more efforts for novel therapeutic options are needed

S Wang, Y Liu, Y Feng, J Zhang, J Swinnen, Y Li, Y Ni - Cancers, 2019 - mdpi.com
Cancer remains a major cause of death globally. Given its relapsing and fatal features,
curing cancer seems to be something hardly possible for the majority of patients. In view of …

[HTML][HTML] Colorectal cancer screening from 45 years of age: thesis, antithesis and synthesis

A Mannucci, RA Zuppardo, R Rosati… - World Journal of …, 2019 - ncbi.nlm.nih.gov
Colorectal cancer incidence and mortality in patients younger than 50 years are increasing,
but screening before the age of 50 is not offered in Europe. Advanced-stage diagnosis and …

Plasma microRNA signature validation for early detection of colorectal cancer

M Herreros-Villanueva, S Duran-Sanchon… - Clinical and …, 2019 - journals.lww.com
OBJECTIVES: Specific microRNA (miRNA) signatures in biological fluids can facilitate
earlier detection of the tumors being then minimally invasive diagnostic biomarkers …